CARLSBAD, Calif. , March 5, 2024 /PRNewswire/ — Today, Limmi – an AI startup dedicated to transforming patient outcomes by rapidly discovering hidden patterns in life sciences data – announced that Professor of Urology at UC San Diego Health, Dr. A. Karim Kader, MD, PhD, FRCSC has joined the company’s Advisory Board as Chairman. In addition to Dr. Kader’s impressive work at UCSD, he also spent 15 years successfully building Stratify Genomics – a biotech company founded to commercialize genetic tests to determine a patient’s risk of developing prostate cancer.
Limmi utilizes cutting-edge AI and deep learning methodologies on a platform built specifically for healthcare and biotech, offering their customers real-time predictions and insights to patients, radically changing the way their customers manage healthcare operations and patient health management.
“We’re in a desperate need at this time for solutions like the one Limmi is offering. We’re creating all this big data that we don’t …